Clinical Nutrition for Diabetes Care Market Report 2025

This Clinical Nutrition for Diabetes Care market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The clinical nutrition for diabetes care market size has grown strongly in recent years. It will grow from $2.93 billion in 2024 to $3.18 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to medical professional advocacy, rise in lifestyle diseases, increased awareness among consumers, healthcare infrastructure development, and rising diabetes prevalence.

The clinical nutrition for diabetes care market size is expected to see strong growth in the next few years. It will grow to $4.32 billion in 2029 at a compound annual growth rate (CAGR) of 8%. The growth in the forecast period can be attributed to insurance coverage for diabetes management, healthcare expenditure, obesity epidemic, aging population, and rising diabetes prevalence. Major trends in the forecast period include increasing focus on immune-supportive nutrition, plant-based nutrition, functional foods and supplements, digital health integration, and personalized nutrition plans.

The rising prevalence of diabetes is expected to drive the growth of the clinical nutrition for diabetes care market in the coming years. Diabetes is a group of metabolic disorders marked by high blood sugar levels over an extended period, caused by either insufficient insulin production or the body's inability to effectively use insulin. The growing prevalence of diabetes is influenced by factors such as sedentary lifestyles, poor diets, genetic predisposition, and aging populations. Clinical nutrition plays a vital role in managing diabetes by providing personalized dietary plans that help regulate blood sugar levels, support weight management, and reduce the risk of complications. For example, the International Diabetes Federation's 2022 Annual Report revealed that approximately 537 million adults worldwide were living with diabetes in 2022. This number is expected to rise to 643 million by 2030 and further to 783 million by 2045. As a result, the increasing prevalence of diabetes is driving the demand for clinical nutrition for diabetes care.

Leading companies in the clinical nutrition for diabetes care market are focusing on developing specialized nutritional formulations to meet the unique dietary needs of diabetes patients, particularly for managing blood sugar levels and supporting overall health. These specialized nutrition products offer balanced nutrition, help control blood sugar levels, and promote overall well-being in individuals with diabetes. For example, in March 2024, Abbott Healthcare Pvt Ltd., a US-based pharmaceutical manufacturer, introduced Ensure Diabetes Care, a nutritional supplement specifically designed for people managing diabetes. This product is scientifically formulated with a low glycemic index and includes a blend of high-quality protein, complex carbohydrates, dietary fiber, and essential vitamins and minerals.

In June 2023, Abbott Laboratories, a US-based healthcare and medical devices company specializing in specialized nutritional products, forged a partnership with the American Diabetes Association (ADA). This collaboration aims to spearhead innovative solutions for diabetes management and care by developing advanced technologies, educational materials, and support systems to empower individuals living with diabetes. The American Diabetes Association (ADA), a US-based nonprofit organization, is dedicated to raising diabetes awareness and providing resources for diabetes education.

Major companies operating in the clinical nutrition for diabetes care market are Pfizer Inc., Bayer AG, Sanofi-Aventis LLC, Abbott Laboratories, Roche Holdings Inc, Medtronic plc, Danone SA, Eli Lilly and Company, Amgen Inc., Senseonics Holdings Inc., Teva Pharmaceutical Industries Ltd, Baxter International Inc., B. Braun Melsungen AG, Glanbia plc, Perrigo Company plc, Dexcom Inc., Nestlé Health Science S.A., Tandem Diabetes Care, Nutricia International Private Limited, MannKind Corp, Omada Health, Senseonics Holdings Inc., Diasome Pharmaceuticals Inc., Zucara Therapeutics Inc, Victus Inc.

North America was the largest region in the clinical nutrition for diabetes care market in 2024. The regions covered in the clinical nutrition for diabetes care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the clinical nutrition for diabetes care market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Clinical nutrition for diabetes care involves providing specialized dietary guidance and nutritional support to individuals managing diabetes, encompassing personalized assessments, meal planning, and education on carbohydrate management, glycemic control, and lifestyle modifications. The primary objective is to optimize nutrition, regulate blood sugar levels, prevent complications, and improve overall health outcomes for those with diabetes.

The main products in the clinical nutrition for diabetes care market include oral nutrition, parenteral nutrition, and enteral feeding formulas. Oral nutrition refers to dietary supplements, drinks, or foods consumed orally to meet the nutritional needs of individuals with diabetes, aiming to effectively manage blood sugar levels. These products cater to patients at various stages of adulthood and pediatrics and are distributed through various channels including online, retail, and institutional sales.

The clinical nutrition for diabetes care market research report is one of a series of new reports that provides clinical nutrition for diabetes care market statistics, including clinical nutrition for diabetes care industry global market size, regional shares, competitors with a clinical nutrition for diabetes care market share, detailed clinical nutrition for diabetes care market segments, market trends and opportunities, and any further data you may need to thrive in the clinical nutrition for diabetes care industry. This clinical nutrition for diabetes care market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The clinical nutrition for diabetes care market consists of revenues earned by entities by providing services such as medical nutrition therapy, dietary counseling, and diabetes self-management education and support. The market value includes the value of related goods sold by the service provider or included within the service offering. The clinical nutrition for diabetes care market also includes sales of oral nutrition supplements, enteral nutrition, glucose control formulas, and low-glycemic index foods. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.